Download scientific diagram | Mecanismo de acción de los antibióticos betalactámicos. Tomado de: (Suárez & Gudiol, ). from publication: Determinación. Antibióticos betalactamicos. Dr. Jairo Cerrato Toxicologo clinico. Penicilinas Cefalosporinas Inhibidores de la Carbapenemicos B-lactamasa. ANTIBIOTICOS BETALACTAMICOS. OC. Osvaldo Cabrera. Updated 13 March Transcript. RESISTENCIA. USOS CLINICOS. AMOXICILINA. DE PRIMERA .
|Published (Last):||12 February 2011|
|PDF File Size:||10.34 Mb|
|ePub File Size:||15.9 Mb|
|Price:||Free* [*Free Regsitration Required]|
Are new antibiotics better than beta-lactams for non-critical inpatients with community-acquired pneumonia?. Medwave se preocupa por su privacidad y la betallactamicos de sus datos personales.
There was a problem providing the content you requested
La probabilidad que futura evidencia cambie las conclusiones presentadas en este resumen es baja, debido a la certeza de la evidencia. Oral moxifloxacin vs high-dosage amoxicillin in the treatment of mild-to-moderate, community-acquired, suspected pneumococcal pneumonia in adults. Abtibioticos atypical coverage for inpatients with community-acquired pneumonia: El resumen de los resultados es el siguiente:.
Beta-lactam antibiotics have been traditionally considered first-line therapy. Effectiveness of beta lactam antibiotics compared with antibiotics active against atypical pathogens in non-severe community acquired pneumonia: Sparfloxacin European Study Group. Vogel F, Lode H. Information reported in a systematic review. Azithromycin versus cefaclor in the treatment of acute bacterial pneumonia. Once-daily sparfloxacin versus high-dosage amoxicillin in the treatment of community-acquired, suspected pneumococcal pneumonia in antibiotifos.
Sobre los desenlaces incluidos betalactqmicos este resumen.
ANTIBIOTICOS BETALACTAMICOS by Osvaldo Cabrera on Prezi
Efficacy and safety of ciprofloxacin in patients with respiratory infections in comparison with amoxycillin.
Safety and efficacy of sequential i.
Moxifloxacin monotherapy versus beta-lactam-based standard therapy for community-acquired pneumonia: Clinical phase III comparative study of intravenous levofloxacin and ceftriaxone in community-acquired pneumonia treatment. New antibiotics could be more effective but the evidence is not clear until now, and its use could entail greater costs, an increase in bacterial resistance and other adverse effects.
Chinese Journal of Antibiotics. Diferencias entre este resumen y otras fuentes. Kinasewitz G, Wood RG. The use of oral temafloxacin compared with a parenteral cephalosporin in hospitalized patients with pneumonia.
A comparative study of levofloxacin and ceftriaxone in the treatment of hospitalized patients with pneumonia. Cochrane Database Syst Rev. Trovafloxacin antibioticoss high-dose amoxicillin 1 g three times daily in the treatment of community-acquired bacterial pneumonia. Clarithromycin versus amoxicillin-clavulanic acid in the treatment of community-acquired pneumonia.
Chuard C, Regamey C. Treatment of community-acquired pneumonia with moxifloxacin: We concluded new antibiotics are not better than beta-lactam antibiotics for the treatment of non-critical inpatients with community-acquired pneumonia in relation to clinical failure or adverse effects.
Infect Dis Clin Practice. Sparfloxacin versus cefaclor in the treatment of patients with community-acquired pneumonia: Information reported in a systematic review, Evaluation of roxithromycin RU versus cephradine in pneumococcal pneumonia.
Planta farmaceutica para antibioticos betalactamicos by Alejandra Ovalle on Prezi
Treatment of community-acquired pneumonia: Empiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized adults. Int J Betalatamicos Agents. Searching in Epistemonikos database, which is maintained by screening betalactmicos databases, we identified six systematic reviews including 36 randomized trials addressing this question.
Efficacy and safety of temafloxacin versus those of amoxicillin in hospitalized adults with community-acquired pneumonia. Study report Study report GFXB Efficacy and safety of azithromycin versus benzylpenicillin or erythromycin in community-acquired pneumonia.